 BOCA RATON, Fla., Sept. 28, 2022 GLOBE NEWSWIRE -- First Wave BioPharma, Inc., NASDAQ: FWBI, First Wave BioPharma or the Company, a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, today announced that James Sapirstein, Chairman, President, and CEO of First Wave BioPharma, will give a presentation and take investor meetings at the Inaugural Roth Healthcare Opportunities Conference taking place October 6, 2022, in New York City. 